297 related articles for article (PubMed ID: 16584984)
1. Quantity of AgNORs in gastric endocrine carcinoid tumours as a potential prognostic tool.
Giuffrè G; Mormandi F; Barresi V; Bordi C; Tuccari G; Barresi G
Eur J Histochem; 2006; 50(1):45-50. PubMed ID: 16584984
[TBL] [Abstract][Full Text] [Related]
2. Differences in AgNOR quantity between colorectal cancer and corresponding metastases: are they useful for prognostic purposes?
Giuffrè G; Barresi G; Speciale G; Sarnelli R; Gioffrè Florio MA; Tuccari G
Eur J Histochem; 1997; 41(2):111-8. PubMed ID: 9271703
[TBL] [Abstract][Full Text] [Related]
3. AgNOR quantity as a prognostic tool in hyperplastic and neoplastic parathyroid glands.
Tuccari G; Abbona GC; Guiffrè G; Papotti M; Gasparri G; Barresi G; Bussolati G
Virchows Arch; 2000 Sep; 437(3):298-303. PubMed ID: 11037351
[TBL] [Abstract][Full Text] [Related]
4. Standardized AgNOR analysis of the invasive tumour front in oral squamous cell carcinomas.
Piffkò J; Bànkfalvi A; Ofner D; Rasch D; Joos U; Schmid KW
J Pathol; 1997 Aug; 182(4):450-6. PubMed ID: 9306967
[TBL] [Abstract][Full Text] [Related]
5. In vivo bromodeoxyuridine labelling index, AgNOR protein expression and DNA content in human tumours.
Trerè D; Ceccarelli C; Danova M; Derenzini M
Eur J Histochem; 1996; 40(1):17-26. PubMed ID: 8741096
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of immunohistochemistry in gastric neuroendocrine (carcinoid) tumors.
Safatle-Ribeiro AV; Ribeiro U; Corbett CE; Iriya K; Kobata CH; Sakai P; Yagi OK; Pinto PE; Zilberstein B; Gama-Rodrigues J
Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):21-8. PubMed ID: 17206073
[TBL] [Abstract][Full Text] [Related]
7. Agnor as a marker of malignant transformation in odontogenic keratocysts.
Piloni MJ; Keszler A; Itoiz ME
Acta Odontol Latinoam; 2005; 18(1):37-42. PubMed ID: 16302459
[TBL] [Abstract][Full Text] [Related]
8. [Nucleolus organizer regions in pathomorphologic tumor diagnosis].
Rüschoff J
Veroff Pathol; 1992; 139():1-144. PubMed ID: 1413987
[TBL] [Abstract][Full Text] [Related]
9. The AgNOR quantity as prognostic parameter in choroidal melanomas: a standardised analysis.
Tuccari G; Giménez-Mas JA; Fedele F; Del-Agua C; Melcon B; Trombetta CJ; Giuffrè G
Anal Cell Pathol; 1999; 19(3-4):163-8. PubMed ID: 10866278
[TBL] [Abstract][Full Text] [Related]
10. Lactoferrin immunoexpression in endometrial carcinomas: relationships with sex steroid hormone receptors (ER and PR), proliferation indices (Ki-67 and AgNOR) and survival.
Giuffrè G; Arena F; Scarfì R; Simone A; Todaro P; Tuccari G
Oncol Rep; 2006 Aug; 16(2):257-63. PubMed ID: 16820900
[TBL] [Abstract][Full Text] [Related]
11. [Analysis of proliferating cell nuclear antigen and nucleolar organizer region in testicular tumors].
Kurisu H; Shimabukuro T; Wada T; Yamamoto M; Shameem IA; Otsuka T; Sakano S; Matsuyama H; Naito K; Yamamoto N
Hinyokika Kiyo; 1993 Aug; 39(8):715-20. PubMed ID: 8104387
[TBL] [Abstract][Full Text] [Related]
12. Comparative evaluation of cell proliferative indices and epidermal growth factor receptor expression in gastric carcinoma.
Prakash I; Mathur RP; Kar P; Ranga S; Talib VH
Indian J Pathol Microbiol; 1997 Oct; 40(4):481-90. PubMed ID: 9444859
[TBL] [Abstract][Full Text] [Related]
13. Proliferating cell nuclear antigen (PCNA) expression as a prognostic indicator for renal cell carcinoma: comparison with tumour grade, mitotic index, and silver-staining nucleolar organizer region numbers.
Delahunt B; Bethwaite PB; Nacey JN; Ribas JL
J Pathol; 1993 Aug; 170(4):471-7. PubMed ID: 8105046
[TBL] [Abstract][Full Text] [Related]
14. Argyrophilic proteins of nucleolar organizer regions (AgNORs) in salivary gland mucoepidermoid carcinoma and its relation to histological grade.
Alaeddini M; Khalili M; Tirgary F; Etemad-Moghadam S
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2008 Jun; 105(6):758-62. PubMed ID: 18299224
[TBL] [Abstract][Full Text] [Related]
15. Malignant ileocaecal serotonin-producing carcinoid tumours: the presence of a solid growth pattern and/or Ki67 index above 1% identifies patients with a poorer prognosis.
Cunningham JL; Grimelius L; Sundin A; Agarwal S; Janson ET
Acta Oncol; 2007; 46(6):747-56. PubMed ID: 17653896
[TBL] [Abstract][Full Text] [Related]
16. AgNOR quantification with special reference to staining patterns.
Rüschoff J; Fauser G; Knüchel R; Hofstädter F
Zentralbl Pathol; 1994 Mar; 140(1):23-30. PubMed ID: 7515669
[TBL] [Abstract][Full Text] [Related]
17. A comparison of proliferating cell nuclear antigen (PCNA) immunostaining, nucleolar organizer region (AgNOR) staining, and histological grading in gastrointestinal stromal tumours.
Yu CC; Fletcher CD; Newman PL; Goodlad JR; Burton JC; Levison DA
J Pathol; 1992 Feb; 166(2):147-52. PubMed ID: 1348532
[TBL] [Abstract][Full Text] [Related]
18. Interphase AgNOR quantity and DNA content in endometrial adenocarcinoma.
Trerè D; Melchiorri C; Chieco P; Marabini A; Derenzini M
Gynecol Oncol; 1994 May; 53(2):202-7. PubMed ID: 8188080
[TBL] [Abstract][Full Text] [Related]
19. Argyrophilic nucleolar organizer region in endoscopically obtained biopsy tissue: a useful predictor of nodal metastasis and prognosis in carcinoma of the stomach.
Kakeji Y; Maehara Y; Orita H; Emi Y; Ichiyoshi Y; Korenaga D; Sugimachi K
J Am Coll Surg; 1996 Jun; 182(6):482-7. PubMed ID: 8646347
[TBL] [Abstract][Full Text] [Related]
20. Two-dimensional agnor evaluation as a prognostic variable in urinary bladder carcinoma: a different approach via total agnor area/nucleus area per cell.
Cucer N; Imamoglu N; Tozak H; Demirtas H; Sarac F; Tatlisen A; Oztürk F
Micron; 2007; 38(6):674-9. PubMed ID: 17011198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
